As biologics and cell and gene therapies continue to advance, manufacturing infrastructure is emerging as a critical det...
As cell and gene therapies move from clinical promise to commercial reality, the industry is increasingly recognising th...
Cell and gene therapies have transformed the treatment landscape for complex diseases, yet scaling these innovations bey...
As biotechnology enters a new phase of disciplined investment and precision-driven innovation, leaders who can bridge sc...
As biologics become increasingly sophisticated and development timelines continue to shrink, the role of Contrac...
At BIO International Convention 2026 in San Diego, BioSpectrum Asia spoke with Dr. Christoffer Norn, Co-founder and CEO ...
As life sciences laboratories embrace automation, digitalisation, and increasingly complex research workflows, technolog...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
As biologics manufacturing continues to evolve, Asia Pacific is emerging as a key region for innovation in process inten...
Cell and gene therapy developers continue to face mounting pressure to improve manufacturing efficiency while maintainin...
Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
As Asia’s biologics ecosystem continues to scale rapidly across monoclonal antibodies, biosimilars, and ad...
As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
